-
ASAM Weekly for April 25th, 2023
Opioid Prescribing and Suicide Risk in the USFull story -
ASAM Weekly for April 18th, 2023
Association Between Daily Alcohol Intake and Risk of All-Cause MortalityFull story -
ASAM Weekly for April 11th, 2023
Genetic Liability for Alcohol Consumption, Alcohol Problems and Suicide AttemptsFull story -
ASAM Weekly for April 4th, 2023
Genetic Loci Underlying Multiple Substance Use DisordersFull story -
ASAM Weekly for March 28, 2023
Human brain effects of DMT assessed via EEG-fMRIFull story -
ASAM Weekly for March 21, 2023
Fatal Poisonings Among Infants and Young Children in the United StatesFull story -
ASAM Weekly for March 14, 2023
Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatmentFull story -
ASAM Weekly for March 7, 2023
Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotineFull story -
ASAM Weekly for February 27, 2023
The Howard Street MethodFull story -
ASAM Weekly for February 21, 2023
The Use of Opioids in the Management of Chronic Pain.Full story -
ASAM Weekly for February 14, 2023
State Cannabis Legalization and Psychosis.Full story -
ASAM Weekly for February 7, 2023
Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States.Full story -
ASAM Weekly for January 31, 2023
A patient recently said to me, “At this point in my life, recovery is not only how I live, it’s who I am.” Although I realize – and have helped him understand – that recurrences can occur in the course of the chronic disease that is addiction, I was able to celebrate with him that he is now “right where he needs to be.”Full story -
ASAM Weekly for January 24, 2023
According to results from the 2021 National Survey on Drug Use and Health, nearly 1 in 3 adults in America had either a substance use disorder (SUD) or any mental illness (AMI) in the past year, almost half of all young adults had either a SUD or AMI, and for many with either (SUD or AMI) the COVID pandemic was a global stressor (NSDUH). Not often captured by NSDUH surveys, incarcerated individuals represent a broad population at high risk for opioid use disorder (OUD) and opioid-overdose deaths.Full story -
ASAM Weekly for January 17, 2023
Pain and addiction have a close relationship. For example, research has shown that three days of opioids prescribed for acute postoperative pain can increase the chances of chronic opioid use.Full story -
ASAM Weekly for December 20, 2022
Recent years in addiction medicine have been transformative, and this year was exceptional. The opioid crisis and the COVID pandemic, being front-of-mind for many, created a sense of awareness in Washington D.C. that we must continue to capitolize on (spelling pun intended) (NPR, NBC).Full story -
ASAM Weekly for January 10, 2023
Defining and diagnosing addiction has evolved over the years with cravings becoming a core component in the conceptualization. As we move forward, machine learning is enabling scientists to identify stable brain patterns that can function as a neuromarker for cravings (food and drugs) and potentially be used in diagnosis and treatment response.Full story -
ASAM Weekly for January 3, 2023
To borrow from a conceptualization about human behavior — a good way to predict future news is to look at past news. This week we present to you the most read news publications of 2022.Full story -
ASAM Weekly for December 27, 2022
Treatments for alcohol withdrawal continue to resonate, particularly updates with benzodiazepine-sparing protocols (JAMA Network Open). Research is identifying cannabis as a possible risk factor for dementia (American Journal of Psychiatry) and concern continues to grow around psychotic disorders and potency (The Lancet Psychiatry).Full story -
ASAM Weekly for December 20, 2022
Full story
The ASAM Weekly
Editors & Staff
Editor-in-Chief: Nicholas Athanasiou, MD, MBA, DFASAM
Emeritus Editor: William Haning, MD, DFAPA, DFASAM
Publications Chair: Nicholas Athanasiou, MD, MBA, DFASAM
Co-Editors: Brandon
Aden, MD, John A. Fromson, MD, Sarah Messmer, MD, Jack Woodside, MD
Please direct customer service inquiries and comments to: ASAMWeekly@ASAM.org
The ASAM Weekly
Advertiser Services & Sales
Ad space is limited and available on a first-paid, first-published basis. To assure your ad will run in the specific issue you select, Insertion Orders must be signed by an authorized person in your organization and accepted by your customer service representative before taking the advertising units out of the active sales inventory. Payment must be received prior to the run date for an ad. Insertion Orders provide several options for payment in full including all major credit cards or check. Pre-approved billing must be arranged directly by an ASAM representative.
To learn more about advertising opportunities
Contact: Claire Rasmussen <crasmussen@asam.org>